New cancer clinical trial: Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer

Published on: June 29, 2018 at 12:00PM
Condition:   Non Small Cell Lung Cancer
Interventions:   Drug: Pembrolizumab;   Radiation: Stereotactic body radiotherapy
Sponsor:   Case Comprehensive Cancer Center
Not yet recruiting
https://ift.tt/2KxiiYB